These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31122600)

  • 1. Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up.
    Ng J; Sheldon RS; Maxey C; Ritchie D; Raj V; Exner DV; Raj SR
    Auton Neurosci; 2019 Jul; 219():42-48. PubMed ID: 31122600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals.
    Ng J; Sheldon RS; Ritchie D; Raj V; Raj SR
    Pacing Clin Electrophysiol; 2019 Feb; 42(2):180-188. PubMed ID: 30488466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in Vasovagal Syncope: A Post Hoc Analysis of the Prevention of Syncope Trials (POST) I and II.
    Deveau AP; Sheldon R; Maxey C; Ritchie D; Doucette S; Parkash R
    Can J Cardiol; 2020 Jan; 36(1):79-83. PubMed ID: 31810744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial.
    Aminorroaya A; Tavolinejad H; Sadeghian S; Jalali A; Alaeddini F; Emkanjoo Z; Mollazadeh R; Bozorgi A; Oraii S; Kiarsi M; Shahabi J; Akbarzadeh MA; Rahimi B; Joharimoghadam A; Mohsenizade A; Mohammadi R; Oraii A; Ariannejad H; Apakuppakul S; Ngarmukos T; Tajdini M
    Am Heart J; 2021 Jul; 237():5-12. PubMed ID: 33689731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for the Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects Trial (POST5).
    Raj SR; Faris PD; Semeniuk L; Manns B; Krahn AD; Morillo CA; Benditt DG; Sheldon RS;
    Am Heart J; 2016 Apr; 174():89-94. PubMed ID: 26995374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludrocortisone for the Prevention of Vasovagal Syncope: A Randomized, Placebo-Controlled Trial.
    Sheldon R; Raj SR; Rose MS; Morillo CA; Krahn AD; Medina E; Talajic M; Kus T; Seifer CM; Lelonek M; Klingenheben T; Parkash R; Ritchie D; McRae M;
    J Am Coll Cardiol; 2016 Jul; 68(1):1-9. PubMed ID: 27364043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being.
    Flevari P; Livanis EG; Theodorakis GN; Zarvalis E; Mesiskli T; Kremastinos DT
    J Am Coll Cardiol; 2002 Aug; 40(3):499-504. PubMed ID: 12142117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
    Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
    Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metoprolol on quality of life in the Prevention of Syncope Trial.
    Sheldon RS; Amuah JE; Connolly SJ; Rose S; Morillo CA; Talajic M; Kus T; Fouad-Tarazi F; Klingenheben T; Krahn AD; Koshman ML; Ritchie D;
    J Cardiovasc Electrophysiol; 2009 Oct; 20(10):1083-8. PubMed ID: 19563364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study.
    Occhetta E; Bortnik M; Audoglio R; Vassanelli C;
    Europace; 2004 Nov; 6(6):538-47. PubMed ID: 15519257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tilt training in patients with vasovagal syncope.
    Gajek J; Zyśko D; Mazurek W
    Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Assessment of the Risk of Vasovagal Syncope During Driving.
    Tan VH; Ritchie D; Maxey C; Sheldon R;
    JACC Clin Electrophysiol; 2016 Apr; 2(2):203-208. PubMed ID: 29766871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of injuries associated with syncope in the prevention of syncope trials.
    Jorge JG; Pournazari P; Raj SR; Maxey C; Sheldon RS
    Europace; 2020 Dec; 22(12):1896-1903. PubMed ID: 32954415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine vs. placebo for the treatment of recurrent vasovagal syncope with anxiety sensitivity.
    Flevari P; Leftheriotis D; Repasos E; Katsaras D; Katsimardos A; Lekakis J
    Europace; 2017 Jan; 19(1):127-131. PubMed ID: 27702846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of dual-chamber pacing with closed loop stimulation on quality of life in patients with recurrent reflex vasovagal syncope: results of the SPAIN study.
    Barón-Esquivias G; Moya-Mitjans A; Martinez-Alday J; Ruiz-Granell R; Lacunza-Ruiz J; Garcia-Civera R; Gutiérrez-Carretero E; Romero-Garrido R; Morillo CA
    Europace; 2020 Feb; 22(2):314-319. PubMed ID: 31713631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clusters, Gaps, and Randomness: Vasovagal Syncope Recurrence Patterns.
    Sahota IS; Maxey C; Pournazari P; Sheldon RS
    JACC Clin Electrophysiol; 2017 Sep; 3(9):1046-1053. PubMed ID: 29759709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of health-related quality of life in autonomic disorders: postural tachycardia syndrome versus vasovagal syncope.
    Hall J; Bourne KM; Sheldon RS; Vernino S; Raj V; Ng J; Okamoto LE; Arnold AC; Bryarly M; Phillips L; Paranjape SY; Raj SR
    Clin Auton Res; 2021 Jun; 31(3):433-441. PubMed ID: 33550497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Ventricular Ejection Fraction and Fractional Shortening are Useful for the Prediction of the Therapeutic Response to Metoprolol in Children with Vasovagal Syncope.
    Song J; Li H; Wang Y; Liu P; Li X; Tang C; Jin H; Du J
    Pediatr Cardiol; 2018 Oct; 39(7):1366-1372. PubMed ID: 29767293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Syncope Trial (POST): a randomized clinical trial of beta blockers in the prevention of vasovagal syncope; rationale and study design.
    Sheldon R; Rose S; Connolly S
    Europace; 2003 Jan; 5(1):71-5. PubMed ID: 12504644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.